Location History:
- Bethesda, MD (US) (2018)
- Washington, DC (US) (2021 - 2024)
Company Filing History:
8 out of 73 
1 out of 1,591 
1 out of 17 
Years Active: 2018-2025
Title: The Innovative Journey of Inventor Catherine M. Bollard
Introduction
Catherine M. Bollard, based in Washington, DC, is a prominent inventor in the field of cancer research. With an impressive portfolio of 7 patents, her work focuses on developing novel methods and compositions for treating and detecting cancer, making significant contributions to medical science and patient care.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 context." This patent encompasses synovial sarcoma X breakpoint 2 binding molecules and methods for their application in the detection and treatment of cancer. Additionally, her patent on "Mycobacterial antigen compositions and methods of use" relates to mycobacterial polynucleotides and polypeptides. This invention includes engineered cells designed to expand T-cells ex vivo, showcasing her dedication to advancing cancer immunotherapy.
Career Highlights
Catherine's impressive career includes significant roles at esteemed institutions such as Children's National Medical Center and Washington University. Her experience in cutting-edge research environments has allowed her to push the boundaries of innovation in cancer treatment.
Collaborations
Throughout her career, Catherine has collaborated with talented professionals, including her notable coworkers Conrad Russell Cruz and Patrick J. Hanley. These collaborations have not only enriched her research but also fostered an environment of innovation and shared knowledge.
Conclusion
Catherine M. Bollard exemplifies the spirit of innovation in the medical field, particularly in cancer research. With her patents and collaborative efforts, she continues to make strides that could transform the landscape of cancer treatment and detection. Her work exemplifies the impact of dedicated inventors on healthcare and the importance of continuous innovation in addressing complex medical challenges.